Aldara

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2016
0246819982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND The application of Aldara(®) cream containing 5% imiquimod stimulates Toll-like receptor 7/8 on plasmacytoid dendritic… (More)
Is this relevant?
2014
2014
Toll-like receptor (TLR) ligands are attractive candidate adjuvants for therapeutic cancer vaccines, since TLR signaling… (More)
Is this relevant?
2014
2014
Psoriasis is a chronic auto-inflammatory skin disease of unknown etiology affecting millions of people worldwide. Dissecting the… (More)
Is this relevant?
2013
2013
Aldara is a cream used for topical treatment of non-melanoma skin cancer, and is thought to act through stimulation of anti… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 5
  • figure 6
Is this relevant?
2005
2005
BACKGROUND Morphoea is characterized by fibrosis, which is mediated by cytokines including transforming growth factor (TGF)-beta… (More)
Is this relevant?
2004
2004
CD30+ anaplastic large cell lymphoma is a primary cutaneous lymphoproliferative disorder with a high rate of spontaneous… (More)
Is this relevant?
2003
2003
We report a case of a lip granulomatous reaction after injection of silicone being treated successfully with topical Aldara… (More)
Is this relevant?
2002
2002
BACKGROUND Imiquimod 5% cream (Aldara, a novel topical immune response modifier, has been approved for the topical treatment of… (More)
Is this relevant?
2000
2000
Lentigo maligna is the in situ phase of lentigo maligna melanoma, and if left untreated it may progress to invasive melanoma. It… (More)
Is this relevant?
1998
1998
Objective: The objective of this single-center, open-label trial was to evaluate the percutaneous penetration of Aldara… (More)
Is this relevant?